Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMOSTEM for steroid-refractory acute or chronic GVHD
NCT01549665Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
A Phase 2 trial of Promostem in graft-versus-host disease (GVHD), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
Promostem
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01549665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549665.